Ciclesonide is more effective than budesonide in the treatment of persistent asthma

Once-daily ciclesonide was more effective than once-daily budesonide in improving FEV1, FVC and PEF. Ciclesonide also had an earlier onset of action than budesonide in patients with persistent asthma. Both ciclesonide and budesonide had good safety and tolerability profiles.